{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T01:56:21Z","timestamp":1676771781484},"reference-count":30,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"ACS-1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.14745\/ccdr.v37i00a01","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T15:07:20Z","timestamp":1519916840000},"page":"1-13","source":"Crossref","is-referenced-by-count":2,"title":["Statement on Protection Against Japanese Encephalitis"],"prefix":"10.14745","volume":"37","author":[{"given":"M.","family":"Tepper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr. S.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5795","published-online":{"date-parts":[[2011,4]]},"reference":[{"issue":"34\/35","key":"key20180301100650_r1","first-page":"331","article-title":"Japanese encephalitis vaccines","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"key20180301100650_r2"},{"key":"key20180301100650_r3","article-title":"Japanese encephalitis vaccines","volume":"59","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key20180301100650_r4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","year":"1992","journal-title":"Epidemiol Rev"},{"issue":"10","key":"key20180301100650_r5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"issue":"6","key":"key20180301100650_r6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0035-9203(94)90201-1","article-title":"The protective effect of bed nets impregnated with pyrethroid insecticide and vaccination against Japanese encephalitis","volume":"88","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"key20180301100650_r7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"key20180301100650_r8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4269\/ajtmh.2010.09-0676","article-title":"Japanese encephalitis in travelers from non-endemic countries, 1973-2008","volume":"82","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"key20180301100650_r9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"GeoSentinel Surveillance Network","year":"2006","journal-title":"N Engl J Med"},{"issue":"46","key":"key20180301100650_r10","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1016\/j.vaccine.2010.09.009","article-title":"Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network","volume":"28","author":"GeoSentinel Surveillance Network","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"key20180301100650_r11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1155\/1991\/678906","article-title":"Imported arbovirus infections in Canada 1974-89","volume":"2","year":"1991","journal-title":"Can J Infect Dis"},{"issue":"5","key":"key20180301100650_r12","first-page":"123","article-title":"Japanese encephalitis in a U.S. traveler returning from Thailand, 2004","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2 Pt 1","key":"key20180301100650_r13","first-page":"331","article-title":"Effectiveness of repellent formulations containing deet against mosquitoes in northeastern Thailand","volume":"12","year":"1996","journal-title":"J Am Mosq Control Assoc"},{"issue":"3","key":"key20180301100650_r14","first-page":"190","article-title":"Laboratory and field evaluations of the insect repellent 3535 (ethyl butylacetylaminopropionate) and deet against mosquito vectors in Thailand","volume":"17","year":"2001","journal-title":"J Am Mosq Control Assoc"},{"issue":"3","key":"key20180301100650_r15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2915.1988.tb00191.x","article-title":"Evaluation of permethrin-impregnated mosquito-nets against mosquitoes in China","volume":"2","year":"1988","journal-title":"Med Vet Entomol"},{"issue":"4","key":"key20180301100650_r16","first-page":"641","article-title":"Relative repellency of two formulations of N,N-diethyl-3-methylbenzamide (deet) and permethrin-treated clothing against Culex sitiens and Aedes vigilax in Thailand","volume":"6","year":"1990","journal-title":"J Am Mosq Control Assoc"},{"key":"key20180301100650_r17","first-page":"1","article-title":"Statement on personal protective measures to prevent arthropod bites","volume":"31","author":"Commitee to Advise on Tropical Medicine and Travel (CATMAT)","year":"2005","journal-title":"Can Commun Dis Rep"},{"key":"key20180301100650_r18","unstructured":"Health Canada. Notice of decision for IXIARO\u00ae [Internet]. 2009 Dec 2 [cited 2010 Jul 12]. Available from: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/prodpharma\/sbd-smd\/phase1-decision\/drug-med\/nd_ad_2009_ixiaro_120330-eng.php"},{"key":"key20180301100650_r19","unstructured":"Intercell AG. Product monograph: IXIARO\u00ae: Japanese encephalitis vaccine (inactivated, adsorbed; suspension for injection [Internet]. 2009 Sep 15 [cited 2010 Jul 13]. Available from: http:\/\/www.novartis.ca\/downloads\/en\/products\/ixiaro_monograph_en.pdf"},{"issue":"3","key":"key20180301100650_r20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.vaccine.2009.10.024","article-title":"Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"key20180301100650_r21","unstructured":"US Food and Drug Administration. March 30, 2009 Approval letter [for IXIARO\u00ae] [Internet]. 2009 Mar 30 [updated 2009 Apr 30; cited 2010 Jul 13]. Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm142577.htm"},{"key":"key20180301100650_r22","unstructured":"European Medicines Agency. European public assessment report: IXIARO [Internet]. 2010 [updated 2010 Apr 20; cited 2010 Jul 30]. Available from: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000963\/human_med_000862.jsp&murl=menus\/medicines\/medicines.jsp&mid=WC0b01ac058001d125"},{"issue":"9602","key":"key20180301100650_r23","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"key20180301100650_r24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","year":"2008","journal-title":"J Infect Dis"},{"issue":"15","key":"key20180301100650_r25","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2008.12.062","article-title":"Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study","volume":"27","year":"2009","journal-title":"Vaccine"},{"issue":"32","key":"key20180301100650_r26","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1016\/j.vaccine.2010.05.069","article-title":"Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51","volume":"28","year":"2010","journal-title":"Vaccine"},{"issue":"34","key":"key20180301100650_r27","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","year":"2008","journal-title":"Vaccine"},{"issue":"33","key":"key20180301100650_r28","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1016\/j.vaccine.2009.05.034","article-title":"Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"key20180301100650_r29"},{"issue":"17","key":"key20180301100650_r30","first-page":"145","article-title":"Evidence-based medicine","volume":"20","author":"Committee to Advise on Tropical Medicine and Travel","year":"1994","journal-title":"Can Commun Dis Rep"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T18:47:20Z","timestamp":1536346040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/11vol37\/acs-1\/pdf\/ccdr_japanese_encephalitis_en.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"ACS-1","published-online":{"date-parts":[[2011,4]]},"published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v37i00a01","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}